Patanjali launches Coronil drug for Covid2019

Patanjali launches Coronil drug for Covid2019

Patanjali claims it can cure coronavirus in 14 days.

Patanjali

MUMBAI: Baba Ramdev's Patanjali launched an ayurvedic medicine for treating Covid2019 today at Patanjali Yogpeeth in Haridwar.

Earlier this month, Patanjali Ayurved managing director Acharya Balkrishna had claimed that an ayurvedic medicine developed by the company has been able to cure Covid2019 patients within five to 14 days. Patanjali Ayurved Ltd MD Acharya Balkrishna had announced the launch on Twitter on Monday evening.

"We've prepared the first ayurvedic clinically-controlled, research, evidence and trial based medicine for Covid2019. We conducted a clinical case study and clinical controlled trial and found 69 per cent patients recovered in three days and 100 per cent patients recovered in seven days," said Ramdev. 

Ramdev claims that there has been 0 per cent death rate and 100 per cent recovery rate has been observed, around 69 per cent of the people recovered within six days. 100 per cent of the people has recovered thanks to the medicine made by it.

He also stated that they have done every research.

"We appointed a team of scientists after Covid2019 outbreak. Firstly, the simulation was done and compounds were identified which can fight the virus and stop its spread in the body. Then, we conducted a clinical case study on hundreds of positive patients and we have got 100 per cent favourable results," Balkrishna said at the launch.

"After taking our medicine, patients recovered in five to 14 days and then tested negative. So, we can say the cure for Covid2019 is possible through Ayurveda. We are performing controlled clinical trials only. In the next four to five days, evidence and data will be released by us," he added.

The medicine has been manufactured by Haridwar’s Divya Pharmacy and Patanjali Ayurved Ltd in Haridwar, based on a joint research by Patanjali Research Institute in Haridwar and the National Institute of Medical Science, Jaipur.